3/26/2009

The FDA has cleared Perrigo's version of Klaron, Sanofi-Aventis' topical acne drug. The final approval allows Perrigo to launch its sulfacetamide sodium topical suspension.

Full Story:
Globes (Israel)

Related Summaries